tradingkey.logo
tradingkey.logo
Search

Palvella Therapeutics Inc

PVLA
Add to Watchlist
139.040USD
-11.150-7.42%
Close 07-31 16:00ETQuotes delayed by 15 min
1.99BMarket Cap
LossP/E TTM

PVLA Financials

See Palvella Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Palvella Therapeutics Inc Earnings Date

Latest Release
Aug 4, 2026
EPS / Forecast
--/-1.16
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-3.71
52.66%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-62.14%-1.20
10.86%-1.07
53.12%-1.03
65.26%-0.86
51.81%-0.74
67.57%-1.20
74.87%-2.19
-167.95%-2.47
89.10%-1.54
57.45%-3.70
---8.70
--3.63
---14.15
---8.71
---27.19
----
----
----
----
----
Revenue
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
-97.26%53.00K
-77.78%1.30M
263.50%19.52M
442.32%20.05M
-82.38%1.94M
-30.76%5.85M
32.36%5.37M
12.57%3.70M
-29.71%10.99M
349.81%8.44M
38.04%4.06M
-70.79%3.29M
Net Profit
-92.63%-15.77M
-109.63%-12.71M
-292.97%-11.35M
-163.82%-9.47M
-199.82%-8.19M
-32.31%-6.07M
73.15%-2.89M
-190.29%-3.59M
79.29%-2.73M
43.42%-4.58M
-10.44%-10.75M
138.46%3.98M
-158.44%-13.18M
15.00%-8.10M
41.12%-9.74M
33.29%-10.34M
-22.27%-5.10M
33.81%-9.53M
-15.77%-16.54M
-213.09%-15.50M
Net Margin
----
----
----
----
----
----
----
----
----
-154.63%-352.89%
---55.08%
--19.83%
---680.94%
---138.59%
---125.52%
----
----
----
----
----
Gross Margin
----
----
----
----
----
----
----
----
----
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
--7.51%
--29.82%
--23.93%
--19.68%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
-97.26%53.00K
-77.78%1.30M
263.50%19.52M
442.32%20.05M
-82.38%1.94M
-30.76%5.85M
32.36%5.37M
12.57%3.70M
-29.71%10.99M
349.81%8.44M
38.04%4.06M
-70.79%3.29M
Operating profit
-88.73%-14.86M
-663.78%-11.30M
-224.63%-10.18M
-121.45%-9.25M
-347.47%-7.87M
68.90%-1.48M
-131.71%-3.13M
-214.53%-4.18M
86.95%-1.76M
58.69%-4.76M
181.25%9.89M
129.58%3.65M
-80.81%-13.48M
-4.73%-11.52M
36.00%-12.17M
26.44%-12.33M
-47.40%-7.46M
11.38%-11.00M
-46.26%-19.01M
-260.06%-16.76M
Net Profit
-92.63%-15.77M
-109.63%-12.71M
-292.97%-11.35M
-163.82%-9.47M
-199.82%-8.19M
-32.31%-6.07M
73.15%-2.89M
-190.29%-3.59M
79.29%-2.73M
43.42%-4.58M
-10.44%-10.75M
138.46%3.98M
-158.44%-13.18M
15.00%-8.10M
41.12%-9.74M
33.29%-10.34M
-22.27%-5.10M
33.81%-9.53M
-15.77%-16.54M
-213.09%-15.50M
Current assets
231.36%263.23M
-33.15%58.99M
226.17%66.94M
194.39%73.75M
169.31%79.44M
128.11%88.23M
-65.27%20.52M
-62.31%25.05M
-51.25%29.50M
-47.32%38.68M
-24.78%59.09M
-26.88%66.47M
-45.86%60.51M
-42.47%73.42M
-42.93%78.56M
-28.80%90.90M
26.60%111.75M
68.55%127.63M
55.26%137.65M
38.73%127.67M
Total current liabilities
1.47%9.12M
-5.77%11.34M
142.41%10.31M
51.53%9.62M
19.25%8.98M
0.97%12.04M
-85.26%4.25M
-81.54%6.35M
-82.43%7.53M
-67.41%11.92M
-13.89%28.87M
-3.31%34.37M
8.59%42.88M
-27.65%36.58M
-32.55%33.52M
-19.08%35.55M
30.46%39.48M
128.32%50.56M
152.43%49.70M
140.57%43.93M
Total assets
232.03%263.76M
-32.50%59.56M
226.17%66.94M
194.39%73.75M
169.31%79.44M
128.11%88.23M
-65.44%20.52M
-71.38%25.05M
-64.14%29.50M
-59.49%38.68M
-40.12%59.38M
-23.41%87.54M
-40.01%82.26M
-37.82%95.49M
-39.60%99.16M
-26.27%114.31M
18.42%137.12M
46.23%153.56M
41.88%164.18M
31.62%155.03M
Total liabilities
31.78%31.45M
23.21%31.58M
564.20%28.25M
309.19%25.97M
216.77%23.86M
114.96%25.63M
-85.26%4.25M
-86.51%6.35M
-88.72%7.53M
-82.35%11.92M
-54.47%28.87M
-32.74%47.05M
-20.16%66.80M
-34.28%67.56M
-42.54%63.40M
-35.42%69.94M
7.89%83.67M
38.96%102.81M
53.17%110.33M
52.31%108.31M
Total equity
318.00%232.31M
-55.30%27.98M
137.78%38.68M
155.44%47.78M
153.04%55.58M
133.97%62.61M
-46.68%16.27M
-53.81%18.70M
42.09%21.96M
-4.19%26.76M
-14.70%30.51M
-8.72%40.50M
-71.08%15.46M
-44.97%27.93M
-33.58%35.77M
-5.04%44.37M
39.79%53.45M
63.58%50.76M
23.26%53.85M
0.10%46.72M
Net operating income
-60.52%-10.86M
-96.25%-4.93M
-5495.89%-7.88M
-267.16%-5.43M
-514.16%-6.77M
87.24%-2.51M
101.50%146.00K
88.98%-1.48M
89.98%-1.10M
-52.08%-19.67M
-10.77%-9.72M
13.78%-13.43M
51.44%-11.00M
-18.17%-12.93M
39.40%-8.78M
-152.09%-15.58M
-86.55%-22.64M
18.43%-10.94M
-91.33%-14.48M
405.85%29.91M
Net investment
---55.44M
----
----
----
----
-428.15%-11.32M
107.16%142.00K
259.30%2.18M
-24.39%9.00M
211.56%3.45M
-136.27%-1.98M
87.43%-1.37M
170.23%11.90M
423.68%1.11M
1662.86%5.47M
-4644.54%-10.87M
-60428.57%-16.95M
-102.30%-342.00K
-101.91%-350.00K
-104.09%-229.00K
Net financing
17964.48%214.73M
-100.06%-49.00K
--242.00K
--349.00K
---1.20M
621964.29%87.09M
--0.00
----
--0.00
-84.95%14.00K
-100.00%0.00
6939.50%19.78M
-100.00%0.00
-98.10%93.00K
-98.71%282.00K
-98.76%281.00K
-32.34%6.56M
6434.67%4.90M
127.72%21.92M
5336.78%22.62M

FAQs

What are the current assets of Palvella Therapeutics Inc?

According to Palvella Therapeutics Inc's FY2025 earnings report, its current assets were 58.99M, with a year-on-year change of -33.15.

What are the total assets of Palvella Therapeutics Inc?

According to Palvella Therapeutics Inc's FY2025 earnings report, its total assets of Palvella Therapeutics Inc were 59.56M, with a year-on-year change of -32.50.

What are the total liabilities of Palvella Therapeutics Inc?

According to Palvella Therapeutics Inc's FY2025 earnings report, its total liabilities of Palvella Therapeutics Inc were 31.58M, with a year-on-year change of 23.21.

What is the total equity of Palvella Therapeutics Inc?

According to Palvella Therapeutics Inc's FY2025 earnings report, its total equity of Palvella Therapeutics Inc was 27.98M, with a year-on-year change of -55.30.

What is the net operating income of Palvella Therapeutics Inc?

According to Palvella Therapeutics Inc's FY2025 earnings report, its net operating income of Palvella Therapeutics Inc was -38.60M, with a year-on-year change of -173.87.

What is the net financing of Palvella Therapeutics Inc?

According to Palvella Therapeutics Inc's FY2025 earnings report, its net financing of Palvella Therapeutics Inc was -660.00K, with a year-on-year change of -100.76.

What is the Earnings Per Share (EPS) of Palvella Therapeutics Inc?

According to Palvella Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.71, with a year-on-year change of 52.66.

What is the net income of Palvella Therapeutics Inc?

According to Palvella Therapeutics Inc's FY2025 earnings report, its net income was -41.72M, with a year-on-year change of -139.27.

What is the debt-to-asset ratio of Palvella Therapeutics Inc?

According to Palvella Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 29.82, with a year-on-year change of 120.32.

What is the Return on Equity (ROE) of Palvella Therapeutics Inc?

According to Palvella Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -92.10, with a year-on-year change of -136.04.

What is the Return on Assets (ROA) of Palvella Therapeutics Inc?

According to Palvella Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -56.45, with a year-on-year change of -105.47.

What is the operating profit of Palvella Therapeutics Inc?

According to Palvella Therapeutics Inc's FY2025 earnings report, its operating profit was -38.60M, with a year-on-year change of -173.87.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.